News & Views
- Q1 adjusted EPS 32.8 pence vs forecast 30 pence
- Q1 turnover 9.78 bln stg vs forecast 9.15 bln
- Consumer health business listing on track for July
- Shares rise about 1.7%
April 27 (Reuters) - GSK (GSK.L) beat first-quarter sales and earnings forecasts on Wednesday, helped by demand for its COVID-19 therapy and shingles vaccine, as the drugmaker moves towards the July separation of its consumer health business.
Source: Reuters
How to join Oxentt ?
To join the exclusive Business Agency elite group does not require important financial contribution. It is, however, imperative that by joining all members adhere to its philosophy of ethics, respect and seriousness.
Any business owner from any country, investor, entrepreneur and corporate executives are welcome to join us.